#alvotech — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #alvotech, aggregated by home.social.
-
Alvotech gets FDA VAI classification for Iceland plant | ALVO SEC Filing
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16…
#Iceland #IS #Europe #Europa #EU #ALVO #Alvotech #AVT05 #AVT06 #AVT16 #biosimilars #Biotechnology #BLA #FDAInspection #iceland #island #VAIclassification
https://www.europesays.com/3162739/ -
Alvotech gets FDA VAI classification for Iceland plant | ALVO SEC Filing https://www.byteseu.com/2238323/ #ALVO #Alvotech #AVT05 #AVT06 #AVT16 #Biosimilars #Biotechnology #BLA #FDAInspection #Iceland #VAIClassification
-
https://www.europesays.com/ch/81407/ Former Roche oncology head turns to Tubulis—Chutes & Ladders #AkronBio #AlloyTherapeutics #Alvotech #argenx #biotech #CharlesRiver #ChutesAndLadders #FierceBiotechHomepage #FlagshipPioneering #Galecto #hiring #JazzPharmaceuticals #LBPharmaceuticals #Novotech #Nuevocor #OrumTherapeutics #PraxisPrecisionMedicines #RemixTherapeutics #Roche #TangoTherapeutics #Tubulis #Vaxxas #Volastra
-
Alvotech and Islandsbanki renew Market Making Agreement for ALVO Shares Trading on Nasdaq Iceland https://www.byteseu.com/2068159/ #agreement #ALVO #Alvotech #and #for #Iceland #Islandsbanki #making #market #NASDAQ #on #renew #shares #trading
-
Alvotech reports completion of FDA inspection in Iceland
Alvotech (NASDAQ:ALVO) announced Monday that the U.S. Food and Drug Administration (FDA) has completed a routine cGMP (current…
#Iceland #IS #Europe #Europa #EU #ALVO #Alvotech #BiologicsLicenseApplication #biosimilars #BLAResubmission #cGMPCompliance #FDAInspection #Form483 #iceland #island #ReykjavikFacility
https://www.europesays.com/2982475/ -
Alvotech reports completion of FDA inspection in Iceland https://www.byteseu.com/2011445/ #ALVO #Alvotech #BiologicsLicenseApplication #Biosimilars #BLAResubmission #CGMPCompliance #FDAInspection #Form483 #Iceland #ReykjavikFacility
-
Avethera übernimmt Fraunhofer-GMP in Braunschweig
Es klingt gepflegt umschreibend, was die Ursache für einen Verkauf des Fraunhofer ITEM-Standortes in Braunschweig angeht: „Aufgrund des…
#Braunschweig #Deutschland #Deutsch #DE #Schlagzeilen #Headlines #Nachrichten #News #Europe #Europa #EU #Alvotech #AndreasHerrmann #AvetheraGmbH #Biosimilars #CDMO #Celonic #FahimeMahboudi #FraunhoferGesellschaft(FhG) #Germany #Hennigsdorf #HZI #Leva #Niedersachsen
https://www.europesays.com/de/901104/ -
Alvotech Reports Positive PK Results for AVT80
Alvotech has announced top-line results from a pivotal pharmacokinetic study of AVT80, a proposed biosimilar to Entyvio (vedolizumab). The randomized, double-blind, 3-arm study assessed PK similarity, safety, and immunogenicity in healthy adults after a single 108 mg/0.68 mL subcutaneous injection. The data supports the development of the candidate for patients worldwide.
-
Alvotech Reports Positive PK Results for AVT80
Alvotech has announced top-line results from a pivotal pharmacokinetic study of AVT80, a proposed biosimilar to Entyvio (vedolizumab). The randomized, double-blind, 3-arm study assessed PK similarity, safety, and immunogenicity in healthy adults after a single 108 mg/0.68 mL subcutaneous injection. The data supports the development of the candidate for patients worldwide.
-
Alvotech Reports Positive PK Results for AVT80
Alvotech has announced top-line results from a pivotal pharmacokinetic study of AVT80, a proposed biosimilar to Entyvio (vedolizumab). The randomized, double-blind, 3-arm study assessed PK similarity, safety, and immunogenicity in healthy adults after a single 108 mg/0.68 mL subcutaneous injection. The data supports the development of the candidate for patients worldwide.
-
Alvotech Reports Positive PK Results for AVT80
Alvotech has announced top-line results from a pivotal pharmacokinetic study of AVT80, a proposed biosimilar to Entyvio (vedolizumab). The randomized, double-blind, 3-arm study assessed PK similarity, safety, and immunogenicity in healthy adults after a single 108 mg/0.68 mL subcutaneous injection. The data supports the development of the candidate for patients worldwide.
-
Alvotech Secures Global Settlement for Aflibercept Biosimilar
Alvotech reached a settlement to market its biosimilar globally. Entry starts Jan 1, 2026, in the UK and Canada. The EEA and other regions follow May 1, 2026. Japan allows full indications by Nov 1, 2026. Combined with a US Q4 2026 license, the company secures worldwide rights to supply partners, subject to regulatory approval.
-
Alvotech Secures Global Settlement for Aflibercept Biosimilar
Alvotech reached a settlement to market its biosimilar globally. Entry starts Jan 1, 2026, in the UK and Canada. The EEA and other regions follow May 1, 2026. Japan allows full indications by Nov 1, 2026. Combined with a US Q4 2026 license, the company secures worldwide rights to supply partners, subject to regulatory approval.
-
Alvotech Secures Global Settlement for Aflibercept Biosimilar
Alvotech reached a settlement to market its biosimilar globally. Entry starts Jan 1, 2026, in the UK and Canada. The EEA and other regions follow May 1, 2026. Japan allows full indications by Nov 1, 2026. Combined with a US Q4 2026 license, the company secures worldwide rights to supply partners, subject to regulatory approval.
-
Alvotech Secures Global Settlement for Aflibercept Biosimilar
Alvotech reached a settlement to market its biosimilar globally. Entry starts Jan 1, 2026, in the UK and Canada. The EEA and other regions follow May 1, 2026. Japan allows full indications by Nov 1, 2026. Combined with a US Q4 2026 license, the company secures worldwide rights to supply partners, subject to regulatory approval.
-
Icelandic BioTech Alvotech secures €100 million term loan facility to bolster liquidity and R&D investment
Alvotech, a Reykjavík-based BioTech company specialising in the development and manufacture of biosimilar medicines, has secured a €100…
#Iceland #IS #Europe #Europa #EU #Alvotech #biosimilars #biotechstartup #GoldenTreeAssetManagement #iceland #island #reykjavik #RobertWessman
https://www.europesays.com/2673155/ -
Icelandic BioTech Alvotech secures €100 million term loan facility to bolster liquidity and R&D investment https://www.byteseu.com/1680675/ #Alvotech #Biosimilars #BiotechStartup #GoldenTreeAssetManagement #Iceland #Reykjavik #RobertWessman